drugset
drugset / Trial / NCT01207596

Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain

NCT01207596 ↗

Phase 4 Completed 30 enrolled International Clinical Research Institute
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to find out if Exalgo (r) is beneficial for the patients with neuropathic pain.

Timeline

Start
2010-09
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydromorphone Other / unclassified — Oral

Indications

neuropathy, painful